Literature DB >> 21480475

Opsoclonus-myoclonus and anti-Hu positive limbic encephalitis in a patient with neuroblastoma.

Andres Morales La Madrid1, Charles M Rubin, Michael Kohrman, Peter Pytel, Susan L Cohn.   

Abstract

Opsoclonus-myoclonus syndrome (OMS) is seen in 2-3% of children with neuroblastoma and is believed to be caused by an autoimmune process elicited by the tumor. Although long-term neurologic sequelae are common in children with OMS, limbic encephalitis has not previously been reported. We report a child who developed limbic encephalitis associated with anti-Hu antibodies, 6 years after her initial diagnosis of neuroblastoma and OMS. This case demonstrates that patients with neuroblastoma and OMS are at risk for developing new paraneoplastic symptoms years after their original diagnosis and emphasizes the need for careful long-term follow-up.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2011        PMID: 21480475     DOI: 10.1002/pbc.23131

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  5 in total

1.  Paraneoplastic neurological syndromes: general treatment overview.

Authors:  Aurélien Viaccoz; Jérôme Honnorat
Journal:  Curr Treat Options Neurol       Date:  2013-04       Impact factor: 3.598

2.  Different Kinds of Paraneoplastic Syndromes in Childhood Neuroblastoma.

Authors:  Yu-Tong Zhang; Li-Hua Feng; Zhen Zhang; Xiao-Dan Zhong; Jian Chang
Journal:  Iran J Pediatr       Date:  2015-02-21       Impact factor: 0.364

3.  Neuroimmunology of OMS and ANNA-1/anti-Hu paraneoplastic syndromes in a child with neuroblastoma.

Authors:  Michael R Pranzatelli; Nathan R McGee
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2017-12-22

Review 4.  Autoimmune encephalitis in children and adolescents.

Authors:  C G Bien; C I Bien
Journal:  Neurol Res Pract       Date:  2020-01-03

5.  Neuroblastoma Among Omani Children: Clinical characteristics and survival outcome from a dedicated centre.

Authors:  Abeer Al-Battashi; Ameera Al-Rahbi; Abdulhakeem Al-Rawahi; Mohammed Mamdouh; Ibrahim Al-Ghaithi; Fatma A Ramadhan
Journal:  Sultan Qaboos Univ Med J       Date:  2021-11-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.